Seven Grand Managers LLC Cuts Holdings in Guardian Pharmacy Services, Inc. (NYSE:GRDN)

Seven Grand Managers LLC cut its position in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) by 33.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 100,000 shares of the company's stock after selling 49,700 shares during the quarter. Seven Grand Managers LLC owned about 0.16% of Guardian Pharmacy Services worth $2,026,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Barclays PLC purchased a new position in Guardian Pharmacy Services in the third quarter valued at approximately $311,000. Investment Research & Advisory Group Inc. purchased a new position in shares of Guardian Pharmacy Services in the 4th quarter valued at $34,000. R Squared Ltd acquired a new position in shares of Guardian Pharmacy Services during the 4th quarter valued at $30,000. Calamos Advisors LLC boosted its position in Guardian Pharmacy Services by 124.7% during the 4th quarter. Calamos Advisors LLC now owns 24,725 shares of the company's stock worth $501,000 after purchasing an additional 13,720 shares during the period. Finally, Compass Financial Services Inc acquired a new stake in Guardian Pharmacy Services in the 4th quarter valued at $58,000.

Analyst Ratings Changes

Separately, Truist Financial boosted their price objective on Guardian Pharmacy Services from $24.00 to $25.00 and gave the stock a "buy" rating in a research note on Friday, April 11th.

Guardian Pharmacy Services Stock Up 2.9%

Guardian Pharmacy Services stock opened at $24.82 on Friday. Guardian Pharmacy Services, Inc. has a 12-month low of $14.16 and a 12-month high of $26.91. The firm's fifty day moving average price is $22.63 and its 200 day moving average price is $21.74.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last announced its earnings results on Monday, May 12th. The company reported $0.21 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.22 by ($0.01). The firm had revenue of $329.31 million during the quarter, compared to analyst estimates of $321.21 million. Equities analysts anticipate that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current year.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.

Want to see what other hedge funds are holding GRDN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.